Price Position and Structural State
Bio Protocol (BIO) closed at 0.03109 USDT on May 29, 2026, up 3.91%. The asset now sits in a sideways structure near the bottom of its 55-day range. Current 55-day support is near 0.01699 USDT, with resistance near 0.066 USDT. A daily close below 0.01699 USDT would confirm a downside regime shift. A hold near support would keep price inside the range.
Moving Averages and Trend Context
BIO is trading below short-term moving averages while still holding above longer-term support. MA9 at 0.032802 USDT may cap short-term recovery attempts, while MA100 at 0.028456 USDT remains the more significant structural support area. The structure resembles a pullback within a broader trend more than a full trend failure.
Trading Friction and Price Efficiency
BIO shows moderate trading friction, with a 3-day friction score of 38.3. The score combines price progress, wick rejection, and volume confirmation. Recent candles show mixed acceptance, so price is moving but still showing some noise. Moves near support or resistance need a cleaner daily close before they carry stronger weight.
Open Interest, Funding, and Positioning
Open interest fell -8.99% in one day and remains near the lower side of its 30-day range. This shows participation is weak and exposure is still being reduced.
Funding is positive on the 24-hour average at +0.003832%, while the 7-day average is -0.003890%. This shows fresh long-side cost pressure rather than a sustained build across the week.
The long/short ratio is 0.55, sitting near the lower side of its 180-day range at 5.65%. This means short accounts dominate, with the long/short reading near the low side of recent history.
Correlation, Beta, and Index Relationship
BIO shows weak linkage to the broader crypto market (Sigloid Index). Correlation is limited, and R² indicates that index behavior explains only a small portion of its movement. This suggests price action is largely driven by asset-specific factors rather than broader market direction. Over the 30-day window, the relationship is stable. Over the 60-day window, the relationship is stable. Over the 180-day window, the relationship is stable.
| Window | Correlation | Beta | R² | Read |
|---|---|---|---|---|
| 30D | 0.251 | 1.546 | 0.063 | Weak linkage |
| 60D | 0.249 | 1.388 | 0.062 | Weak linkage |
| 180D | 0.429 | 1.128 | 0.184 | Moderate linkage |
Momentum, Volatility, and Indicator Pressure
BIO's volatility profile is controlled rather than stretched. ATR% reads 14.08, near the middle of its full historical range. Bollinger Band width% reads 65.10, close to the bottom of its 30-day range. 20-day Volume Z-score is -0.74. Range expansion is not leading the setup right now.
Momentum is weaker. RSI is 40.66, ROC14 is -25.60%, and MACD histogram is negative. These readings point in the same direction: downside pressure is active, while recovery pressure remains limited.
The read is cautious: downside momentum is active, but volatility and participation do not confirm a strong break yet.
Broader Market Regime
The Sigloid Index remains in a sideways regime, showing no clear broad market direction. BIO has a weak link to that market condition, so price behavior depends mainly on asset specific structure rather than the broader market.
Key Levels for the Next State Change
For BIO, the next structural shift depends on range boundaries. A daily close above 55-day resistance at 0.066 USDT establishes a bullish regime, while a daily close below 55-day support at 0.01698 USDT confirms a bearish regime.